Between 2013 and 2023, Vietnam experienced fluctuations in the number of scientific publications in drug discovery. Starting from a modest 9.2 publications in 2013, the sector has seen considerable growth, reaching 38.2 publications by 2023. The annual year-on-year variations highlight a landscape that has experienced both robust growth and occasional declines. For instance, the year-on-year variation peaked in 2017 at 38.87% but also dipped in 2016 with a -9.09% decline. Over the past decade, the compounded annual growth rate (CAGR) ranged from 11.65% in 2023 to a high of 23.68% in 2014. For the past five years, the sector has maintained an average annual growth rate (CAGR) of 5.35%, with an overall forecasted 5-year growth rate of 29.77% by 2028.

Future trends to watch for:

Emerging partnerships with global pharmaceutical firms
Enhanced government funding for research and development
Increased focus on innovative technologies and methodologies in drug discovery
Potential regional collaborations within Southeast Asia
Impact of digital transformation and artificial intelligence on research outputs